TCR2, Avedro wrangle $145M in first life science IPOs of 2019

After a year-end high, a crackdown on foreign investment and a government shutdown, Massachusetts saw its first biotech IPOs of 2019 this week.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.